135 related articles for article (PubMed ID: 11392545)
21. Kinetic characterization of the chymotryptic activity of the 20S proteasome.
Stein RL; Melandri F; Dick L
Biochemistry; 1996 Apr; 35(13):3899-908. PubMed ID: 8672420
[TBL] [Abstract][Full Text] [Related]
22. The bovine lung 20S proteasome binding to reversible inhibitors: modulation by sodium ion.
Eleuteri AM; Angeletti M
FEBS Lett; 2003 Jul; 547(1-3):7-10. PubMed ID: 12860377
[TBL] [Abstract][Full Text] [Related]
23. Towards subunit-specific proteasome inhibitors: synthesis and evaluation of peptide alpha',beta'-epoxyketones.
Elofsson M; Splittgerber U; Myung J; Mohan R; Crews CM
Chem Biol; 1999 Nov; 6(11):811-22. PubMed ID: 10574782
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of the chymotrypsin-like activity of the pituitary multicatalytic proteinase complex.
Vinitsky A; Michaud C; Powers JC; Orlowski M
Biochemistry; 1992 Oct; 31(39):9421-8. PubMed ID: 1356435
[TBL] [Abstract][Full Text] [Related]
25. Glutathiolation of the proteasome is enhanced by proteolytic inhibitors.
Demasi M; Shringarpure R; Davies KJ
Arch Biochem Biophys; 2001 May; 389(2):254-63. PubMed ID: 11339815
[TBL] [Abstract][Full Text] [Related]
26. Proteasome active sites allosterically regulate each other, suggesting a cyclical bite-chew mechanism for protein breakdown.
Kisselev AF; Akopian TN; Castillo V; Goldberg AL
Mol Cell; 1999 Sep; 4(3):395-402. PubMed ID: 10518220
[TBL] [Abstract][Full Text] [Related]
27. TMC-89A and B, new proteasome inhibitors from streptomyces sp. TC 1087.
Koguchi Y; Nishio M; Suzuki S; Takahashi K; Ohnuki T; Komatsubara S
J Antibiot (Tokyo); 2000 Sep; 53(9):967-72. PubMed ID: 11099231
[No Abstract] [Full Text] [Related]
28. Tyropeptins A and B, new proteasome inhibitors produced by Kitasatospora sp. MK993-dF2. I. Taxonomy, isolation, physico-chemical properties and biological activities.
Momose I; Sekizawa R; Hashizume H; Kinoshita N; Homma Y; Hamada M; Iinuma H; Takeuchi T
J Antibiot (Tokyo); 2001 Dec; 54(12):997-1003. PubMed ID: 11858671
[TBL] [Abstract][Full Text] [Related]
29. Novel beta-lactam derivatives: potent and selective inhibitors of the chymotrypsin-like activity of the human 20S proteasome.
Imbach P; Lang M; García-Echeverría C; Guagnano V; Noorani M; Roesel J; Bitsch F; Rihs G; Furet P
Bioorg Med Chem Lett; 2007 Jan; 17(2):358-62. PubMed ID: 17095212
[TBL] [Abstract][Full Text] [Related]
30. Antitumor effect of the human immunodeficiency virus protease inhibitor ritonavir: induction of tumor-cell apoptosis associated with perturbation of proteasomal proteolysis.
Gaedicke S; Firat-Geier E; Constantiniu O; Lucchiari-Hartz M; Freudenberg M; Galanos C; Niedermann G
Cancer Res; 2002 Dec; 62(23):6901-8. PubMed ID: 12460905
[TBL] [Abstract][Full Text] [Related]
31. Organic copper complexes as a new class of proteasome inhibitors and apoptosis inducers in human cancer cells.
Daniel KG; Gupta P; Harbach RH; Guida WC; Dou QP
Biochem Pharmacol; 2004 Mar; 67(6):1139-51. PubMed ID: 15006550
[TBL] [Abstract][Full Text] [Related]
32. Functional interaction of poly(ADP-ribose) with the 20S proteasome in vitro.
Mayer-Kuckuk P; Ullrich O; Ziegler M; Grune T; Schweiger M
Biochem Biophys Res Commun; 1999 Jun; 259(3):576-81. PubMed ID: 10364460
[TBL] [Abstract][Full Text] [Related]
33. Changes in the expression and the enzymic properties of the 20S proteasome in sugar-starved maize roots. evidence for an in vivo oxidation of the proteasome.
Basset G; Raymond P; Malek L; Brouquisse R
Plant Physiol; 2002 Mar; 128(3):1149-62. PubMed ID: 11891269
[TBL] [Abstract][Full Text] [Related]
34. The selective proteasome inhibitors lactacystin and epoxomicin can be used to either up- or down-regulate antigen presentation at nontoxic doses.
Schwarz K; de Giuli R; Schmidtke G; Kostka S; van den Broek M; Kim KB; Crews CM; Kraft R; Groettrup M
J Immunol; 2000 Jun; 164(12):6147-57. PubMed ID: 10843664
[TBL] [Abstract][Full Text] [Related]
35. Crystal structure of the 20 S proteasome:TMC-95A complex: a non-covalent proteasome inhibitor.
Groll M; Koguchi Y; Huber R; Kohno J
J Mol Biol; 2001 Aug; 311(3):543-8. PubMed ID: 11493007
[TBL] [Abstract][Full Text] [Related]
36. Probing the specificity of the bovine pituitary multicatalytic proteinase complex by inhibitors, activators, and by chemical modification.
Wilk S; Pereira M; Yu B
Biomed Biochim Acta; 1991; 50(4-6):471-8. PubMed ID: 1801711
[No Abstract] [Full Text] [Related]
37. Synthesis of new 3-alkoxy-7-amino-4-chloro-isocoumarin derivatives as new beta-amyloid peptide production inhibitors and their activities on various classes of protease.
Bihel F; Quéléver G; Lelouard H; Petit A; Alvès da Costa C; Pourquié O; Checler F; Thellend A; Pierre P; Kraus JL
Bioorg Med Chem; 2003 Jul; 11(14):3141-52. PubMed ID: 12818677
[TBL] [Abstract][Full Text] [Related]
38. Caspase and proteasome activity during staurosporin-induced apoptosis in lens epithelial cells.
Andersson M; Sjöstrand J; Petersen A; Honarvar AK; Karlsson JO
Invest Ophthalmol Vis Sci; 2000 Aug; 41(9):2623-32. PubMed ID: 10937575
[TBL] [Abstract][Full Text] [Related]
39. Subunit arrangement in the human 20S proteasome.
Kopp F; Hendil KB; Dahlmann B; Kristensen P; Sobek A; Uerkvitz W
Proc Natl Acad Sci U S A; 1997 Apr; 94(7):2939-44. PubMed ID: 9096325
[TBL] [Abstract][Full Text] [Related]
40. A new structural class of proteasome inhibitors that prevent NF-kappa B activation.
Lum RT; Kerwar SS; Meyer SM; Nelson MG; Schow SR; Shiffman D; Wick MM; Joly A
Biochem Pharmacol; 1998 May; 55(9):1391-7. PubMed ID: 10076530
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
